Oric Pharmaceuticals (ORIC) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $12.35, -3.29% vs the prior close of $12.77.
- Volume 945.56K shares, 0.7x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
ORIC slides 3.3% to $12.35. Closed at $12.35, -3.29% vs the prior close of $12.77. Day range $12.04–$12.75, opened at $12.75.
ORIC daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — ORIC slides 3.3% to $12.35
- Closed at $12.35, -3.29% vs the prior close of $12.77. Day range $12.04–$12.75, opened at $12.75.
- Volume was 945.56K shares, 0.7x its 50-day average of 1.34M.
- Price is -4.8% vs its 50-day average ($12.97) and +12.0% vs its 200-day average ($11.02).
- 52-week range $7.23–$14.68; today's close sits at 69% of that range, 15.9% below the 52-week high.
Oct 15, 2026 — ORIC jumps 10.2% to $12.77
- Closed at $12.77, +10.18% vs the prior close of $11.59. Day range $11.53–$12.89, opened at $11.74.
- Volume was 1.56M shares, 1.2x its 50-day average of 1.35M.
- Price is -1.6% vs its 50-day average ($12.98) and +16.1% vs its 200-day average ($11.00).
- 52-week range $7.23–$14.68; today's close sits at 74% of that range, 13.0% below the 52-week high.
Oct 14, 2026 — ORIC rises 2.5% to $11.59
- Closed at $11.59, +2.48% vs the prior close of $11.31. Day range $11.20–$11.84, opened at $11.35.
- Volume was 1.79M shares, 1.3x its 50-day average of 1.42M.
- Price is -10.7% vs its 50-day average ($12.98) and +5.6% vs its 200-day average ($10.98).
- 52-week range $7.23–$14.68; today's close sits at 59% of that range, 21.0% below the 52-week high.
Oct 13, 2026 — ORIC slides 4.2% to $11.31, a 1-month low, 3 down days in a row
- Closed at $11.31, -4.23% vs the prior close of $11.81. Day range $11.29–$11.91, opened at $11.68.
- Volume was 1.16M shares, 0.8x its 50-day average of 1.44M.
- Price is -13.1% vs its 50-day average ($13.02) and +3.2% vs its 200-day average ($10.96).
- 52-week range $7.23–$14.68; today's close sits at 55% of that range, 23.0% below the 52-week high.
- That makes 3 straight losses.
Oct 12, 2026 — ORIC dips 1.5% to $11.81, a 1-month low
- Closed at $11.81, -1.50% vs the prior close of $11.99. Day range $11.73–$12.26, opened at $12.06.
- Volume was 878.30K shares, 0.6x its 50-day average of 1.45M.
- Price is -9.2% vs its 50-day average ($13.01) and +7.9% vs its 200-day average ($10.95).
- 52-week range $7.23–$14.68; today's close sits at 61% of that range, 19.6% below the 52-week high.
Oct 9, 2026 — ORIC dips 0.3% to $11.99
- Closed at $11.99, -0.33% vs the prior close of $12.03. Day range $11.90–$12.29, opened at $11.98.
- Volume was 1.09M shares, 0.7x its 50-day average of 1.47M.
- Price is -7.7% vs its 50-day average ($12.99) and +9.7% vs its 200-day average ($10.93).
- 52-week range $7.23–$14.68; today's close sits at 64% of that range, 18.3% below the 52-week high.
Oct 8, 2026 — ORIC ends flat (+0.2%) to $12.03 on 1.9x normal volume
- Closed at $12.03, +0.17% vs the prior close of $12.01. Day range $10.93–$12.20, opened at $11.87.
- Volume was 2.70M shares, 1.9x its 50-day average of 1.45M — unusually heavy trading.
- Price is -7.4% vs its 50-day average ($12.99) and +10.2% vs its 200-day average ($10.91).
- 52-week range $7.23–$14.68; today's close sits at 64% of that range, 18.1% below the 52-week high.
Oct 7, 2026 — ORIC ends flat (+0.3%) to $12.01
- Closed at $12.01, +0.25% vs the prior close of $11.98. Day range $11.81–$12.43, opened at $11.83.
- Volume was 790.80K shares, 0.5x its 50-day average of 1.46M — lighter than usual.
- Price is -7.4% vs its 50-day average ($12.97) and +10.3% vs its 200-day average ($10.89).
- 52-week range $7.23–$14.93; today's close sits at 62% of that range, 19.6% below the 52-week high.
Oct 6, 2026 — ORIC slides 4.1% to $11.98, a 1-month low
- Closed at $11.98, -4.08% vs the prior close of $12.49. Day range $11.56–$12.60, opened at $12.60.
- Volume was 2.09M shares, 1.4x its 50-day average of 1.45M.
- Price is -7.6% vs its 50-day average ($12.97) and +10.2% vs its 200-day average ($10.87).
- 52-week range $7.23–$14.93; today's close sits at 62% of that range, 19.8% below the 52-week high.
Oct 5, 2026 — ORIC rises 2.3% to $12.49
- Closed at $12.49, +2.34% vs the prior close of $12.20. Day range $11.89–$12.65, opened at $12.65.
- Volume was 1.40M shares, 0.9x its 50-day average of 1.49M.
- Price is -3.7% vs its 50-day average ($12.97) and +15.1% vs its 200-day average ($10.85).
- 52-week range $7.23–$14.93; today's close sits at 68% of that range, 16.3% below the 52-week high.
Oct 2, 2026 — ORIC dips 2.5% to $12.20
- Closed at $12.20, -2.52% vs the prior close of $12.52. Day range $12.16–$12.93, opened at $12.72.
- Volume was 1.23M shares, 0.8x its 50-day average of 1.51M.
- Price is -5.8% vs its 50-day average ($12.96) and +12.6% vs its 200-day average ($10.84).
- 52-week range $7.23–$14.93; today's close sits at 65% of that range, 18.3% below the 52-week high.
ORIC latest news & SEC filings
Every SEC filing by or about ORIC in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 2, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Heyman Richard A. converted options/RSUs into 3,500 shares at $1.60 (≈$5.60K) on Oct 1, 2026; now holds 41,800
- Heyman Richard A. sold 3,500 shares at $12.91 (≈$45.20K) on Oct 1, 2026; now holds 38,300
- Heyman Richard A. sold 3,200 shares at $12.91 (≈$41.33K) on Oct 1, 2026; now holds 203,472
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Oct 1, 2026 · Form 144 — Planned insider sale
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Oct 1, 2026 · Form 144 — Planned insider sale
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Sep 29, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Piscitelli Dominic converted options/RSUs into 13,400 shares at $4.36 (≈$58.42K) on Sep 28, 2026; now holds 83,228
- Piscitelli Dominic sold 13,400 shares at $13.53 (≈$181.26K) on Sep 28, 2026; now holds 69,828
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 25, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Piscitelli Dominic converted options/RSUs into 600 shares at $4.36 (≈$2.62K) on Sep 24, 2026; now holds 70,428
- Piscitelli Dominic sold 100 shares at $13.50 (≈$1.35K) on Sep 24, 2026; now holds 70,328
- Piscitelli Dominic sold 500 shares at $13.51 (≈$6.75K) on Sep 24, 2026; now holds 69,828
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Aug 28, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Piscitelli Dominic sold 77,000 shares at $13.69 (≈$1.05M) on Aug 26, 2026
- Piscitelli Dominic sold 77,000 shares at $13.69 (≈$1.05M) on Aug 26, 2026
- Piscitelli Dominic sold 77,000 shares at $13.69 (≈$1.05M) on Aug 26, 2026
- Piscitelli Dominic sold 77,000 shares at $13.69 (≈$1.05M) on Aug 26, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Aug 3, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Net income: -$41.49M (prior year -$36.35M) (loss widened vs Jun 30, 2025)
- Diluted EPS: -$0.38 (prior year -$0.47) (loss narrowed vs Jun 30, 2025)
Aug 3, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Jul 30, 2026 · Form S-8 — Employee share plan registration
Registration of shares for employee stock plans (S-8)
Jul 30, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
Jun 22, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
- Item 5.07 — Reported shareholder vote results.
Things to know before you trade ORIC
- Last results release: Aug 3, 2026 (8-K Item 2.02). Previous ones: May 4, 2026, Feb 23, 2026, Nov 13, 2025. Based on that rhythm, the next report is likely around Nov 2, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 2.54% (largest 10.2%).
- Liquidity: about 1.50M shares (≈$18.55M) trade per day on average.
- 52-week position: $12.35 vs a range of $7.23–$14.68 (69% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 25 sales; latest: Dominic Piscitelli sold 13,400 shares on Sep 28, 2026.
- Latest filings: 10-Q Aug 3, 2026; 8-K Aug 3, 2026; 8-K Jul 30, 2026.
- Share count: 103.65M shares outstanding (Jul 27, 2026), +6.7% vs a year earlier — notable dilution.
- Listing: Nasdaq · industry: Pharmaceutical Preparations.
ORIC market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 12.75 | 12.75 | 12.04 | 12.35 | 945.56K |
| Oct 15, 2026 | 11.74 | 12.89 | 11.53 | 12.77 | 1.56M |
| Oct 14, 2026 | 11.35 | 11.84 | 11.20 | 11.59 | 1.79M |
| Oct 13, 2026 | 11.68 | 11.91 | 11.29 | 11.31 | 1.16M |
| Oct 12, 2026 | 12.06 | 12.26 | 11.73 | 11.81 | 878.30K |
| Oct 9, 2026 | 11.98 | 12.29 | 11.90 | 11.99 | 1.09M |
| Oct 8, 2026 | 11.87 | 12.20 | 10.93 | 12.03 | 2.70M |
| Oct 7, 2026 | 11.83 | 12.43 | 11.81 | 12.01 | 790.80K |
| Oct 6, 2026 | 12.60 | 12.60 | 11.56 | 11.98 | 2.09M |
| Oct 5, 2026 | 12.65 | 12.65 | 11.89 | 12.49 | 1.40M |
| Oct 2, 2026 | 12.72 | 12.93 | 12.16 | 12.20 | 1.23M |
| Oct 1, 2026 | 13.42 | 13.61 | 12.51 | 12.52 | 1.77M |
| Sep 30, 2026 | 13.51 | 14.12 | 13.33 | 13.47 | 1.96M |
| Sep 29, 2026 | 13.23 | 13.42 | 12.76 | 13.37 | 977.30K |
| Sep 28, 2026 | 13.14 | 13.72 | 12.76 | 13.27 | 1.52M |
| Sep 25, 2026 | 13.27 | 13.49 | 12.94 | 13.16 | 2.49M |
| Sep 24, 2026 | 13.22 | 13.51 | 12.78 | 13.18 | 2.00M |
| Sep 23, 2026 | 13.94 | 14.00 | 12.94 | 13.33 | 1.72M |
| Sep 22, 2026 | 12.73 | 13.53 | 12.54 | 13.50 | 1.16M |
| Sep 21, 2026 | 12.98 | 13.01 | 12.50 | 12.67 | 836.00K |
About Oric Pharmaceuticals
Oric Pharmaceuticals (ORIC) is listed on the Nasdaq and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in SOUTH SAN FRANCISCO, CA. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1796280.
ORIC board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Jacob Chacko | PRESIDENT AND CEO | Jan 6, 2026 |
| Mardi Dier | Director | Jan 6, 2026 |
| Richard A. Heyman | Director | Jul 28, 2026 |
| Steven L. Hoerter | Director | Jan 6, 2026 |
| Lori Anne Kunkel | Director | Jan 6, 2026 |
| Angie You | Director | Jan 6, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Jacob Chacko | PRESIDENT AND CEO | Jan 6, 2026 |
| Pratik S Multani | Chief Medical Officer | Jan 6, 2026 |
| Dominic Piscitelli | Chief Financial Officer | Sep 29, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Sep 28, 2026 | Dominic Piscitelli | Sale | 13,400 | $13.53 |
| Sep 28, 2026 | Dominic Piscitelli | Sale | 13,400 | $13.53 |
| Sep 28, 2026 | Dominic Piscitelli | Sale | 13,400 | $13.53 |
| Sep 28, 2026 | Dominic Piscitelli | Sale | 13,400 | $13.53 |
| Sep 24, 2026 | Dominic Piscitelli | Sale | 100 | $13.50 |
| Sep 24, 2026 | Dominic Piscitelli | Sale | 500 | $13.51 |
| Sep 24, 2026 | Dominic Piscitelli | Sale | 100 | $13.50 |
| Sep 24, 2026 | Dominic Piscitelli | Sale | 500 | $13.51 |
| Sep 24, 2026 | Dominic Piscitelli | Sale | 100 | $13.50 |
| Sep 24, 2026 | Dominic Piscitelli | Sale | 500 | $13.51 |
| Sep 24, 2026 | Dominic Piscitelli | Sale | 100 | $13.50 |
| Sep 24, 2026 | Dominic Piscitelli | Sale | 500 | $13.51 |
| Aug 26, 2026 | Dominic Piscitelli | Sale | 77,000 | $13.69 |
| Aug 26, 2026 | Dominic Piscitelli | Sale | 77,000 | $13.69 |
| Aug 26, 2026 | Dominic Piscitelli | Sale | 77,000 | $13.69 |
ORIC financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | — | $-129.47M | -1.47 | $-110.97M |
| Dec 31, 2024 | — | $-127.85M | -1.83 | $-112.66M |
| Dec 31, 2023 | — | $-100.70M | -1.96 | $-85.69M |
| Dec 31, 2022 | — | $-89.12M | -2.25 | $-75.14M |
| Dec 31, 2021 | — | $-78.72M | -2.07 | $-59.54M |
Latest balance sheet: total assets $404.69M, total liabilities $23.43M, cash $37.48M (as of Jun 30, 2026).
ORIC earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 3, 2026 | 8-K Item 2.02 (results) | $10.60 |
| May 4, 2026 | 8-K Item 2.02 (results) | $9.63 |
| Feb 23, 2026 | 8-K Item 2.02 (results) | $11.71 |
| Nov 13, 2025 | 8-K Item 2.02 (results) | $12.19 |
| Aug 12, 2025 | 8-K Item 2.02 (results) | $9.52 |
| May 5, 2025 | 8-K Item 2.02 (results) | $5.70 |
| Feb 18, 2025 | 8-K Item 2.02 (results) | $7.85 |
| Nov 12, 2024 | 8-K Item 2.02 (results) | $10.26 |
| Aug 12, 2024 | 8-K Item 2.02 (results) | — |
| May 6, 2024 | 8-K Item 2.02 (results) | — |
| Mar 11, 2024 | 8-K Item 2.02 (results) | — |
| Jan 9, 2024 | 8-K Item 2.02 (results) | — |
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)Merck (MRK)AbbVie (ABBV)Abbott Laboratories (ABT)Pfizer (PFE)Bristol Myers Squibb (BMY)Vertex Pharmaceuticals Inc / Ma (VRTX)Novo Nordisk A S (NVO)Regeneron Pharmaceuticals (REGN)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on ORIC
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.